Back to UBS Group AG UBS Group AG

ERNAERNA
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in ERNEXA THERAPEUTICS INC

UBS Group AG previously held 0 shares of ERNA (ERNEXA THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1,008

Total Shares Change

-548

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$6.65
0
2026-Q1
Increased
21,233
+3438.8%
$4,2250.0%$0.30
16
2025-Q4
New
600
-
$7200.0%$1.17
17
2025-Q3
Exited
0
-100.0%
$00.0%$1.17
0
2025-Q2
New
548
-
$1,0080.0%$1.85
17

Other major holders of ERNA: Corient Private Wealth LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used